IBM Statement on United States Withdrawal from the Paris Agreement

Share this post:

Washington, D.C. – IBM (NYSE: IBM) today issued this statement on the United States’ decision to withdraw from the Paris Agreement:

“IBM has stated its position on climate change publicly since 2007: Climate change is a serious concern that warrants meaningful action on a global basis to stabilize the atmospheric concentration of greenhouse gas emissions.

“Climate change is an international problem that requires an international solution, and we believe it is important for the world to reduce greenhouse gas emissions. Therefore IBM supported — and still supports — U.S. participation in the Paris Agreement. This agreement requires all participating countries to put forward their best efforts on climate change as determined by each country. IBM believes that it is easier to lead outcomes by being at the table, as a participant in the agreement, rather than from outside it.

“Whether the U.S. participates in the Paris Agreement or not, IBM will continue its decades-long work to reduce its own greenhouse gas emissions and will continue to help our clients do so as well.”

 

Read more about IBM and the environment here.

###
Media Contact:
Rachel Thomas
External Relations, IBM
rachel.r.thomas@ibm.com

More Uncategorized Stories

IBM Statement on Privacy Shield Review

IBM today expressed its support for a positive result in the first annual review of Privacy Shield, a deal vital to both the EU and US economies.

Continue reading

A Cyber-secure Europe: What the New EU Strategy Needs to Deliver

IBM cybersecurity policy expert Nick Coleman outlines priority objectives for the EU's newly unveiled Cyber Security Strategy.

Continue reading

IBM and a Century of American Investment

For more than 100 years, IBM’s story has been deeply linked to major milestones in American history. Our U.S. investments have led to groundbreaking innovations, from helping send men to the moon on the Apollo missions or creating first-of-their-kind cognitive systems that are helping the US lead the fight against cancer, disease, and epidemics. IBM’s […]

Continue reading